Specialized podosome-or invadopodia-like structures (PILS) for focal trabecular meshwork extracellular matrix turnover

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 12, 2008, Pages 5353-5365

  Aga, Mini ^a   Bradley, John M ^a   Keller, Kate E ^a   Kelley, Mary J ^a   Acott, Ted S ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN RELATED PROTEIN 3; ALPHA ACTININ; ALPHA5 INTEGRIN; BETA1 INTEGRIN; CALDESMON; COLLAGEN TYPE 1; CORTACTIN; FIBRONECTIN; FLUORESCEIN ISOTHIOCYANATE; GELATINASE A; MATRIX METALLOPROTEINASE 14; NEURAL WISKOTT ALDRICH SYNDROME PROTEIN; PROTEIN CDC42; VERSICAN; BIOLOGICAL MARKER;

ANIMAL TISSUE; ANTERIOR EYE SEGMENT; AQUEOUS HUMOR OUTFLOW; ARTICLE; CELL MOTION; CELL STRUCTURE; CELLULAR DISTRIBUTION; COLLAGEN DEGRADATION; CONFOCAL MICROSCOPY; CONJUGATION; CONTROLLED STUDY; ENZYME METABOLISM; EXTRACELLULAR MATRIX; HOMEOSTASIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERNALIZATION; INTRAOCULAR PRESSURE; INVADOPODIUM LIKE STRUCTURE; NONHUMAN; ORGAN CULTURE; PODOSOME; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SWINE; TRABECULAR MESHWORK; ANIMAL; CELL SURFACE; METABOLISM; ORGAN CULTURE TECHNIQUE;

ANIMALS; BIOLOGICAL MARKERS; CELL SURFACE EXTENSIONS; EXTRACELLULAR MATRIX; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 2; MICROSCOPY, CONFOCAL; ORGAN CULTURE TECHNIQUES; SWINE; TRABECULAR MESHWORK;

EID: 58149240485     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.07-1666     Document Type: Article

References (94)

1. Quigley HA. Open-angle glaucoma. N Engl J Med. 1993;328:1097-1106.
2. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol. 1996;80:389-393.
3. Shields MB. Textbook of Glaucoma. 4th ed. Baltimore: Williams & Wilkins; 1998.
4. Boland MV, Quigley HA. Risk factors and open-angle glaucoma: classification and application. J Glaucoma. 2007;16:406-418. (Pubitemid 46945541)
5. Bill A, Maepea O. Mechanisms and routes of aqueous humor drainage. In: Albert DM, Jakotiec FA, eds. Principles and Practices of Ophthalmology. Philadelphia: WB Saunders; 1994:206-226.
6. Maepea O, Bill A. Pressures in the juxtacanalicular tissue and Schlemm's canal in monkeys. Exp Eye Res. 1992;54:879-883.
7. Grant WM. Experimental aqueous perfusion in enucleated human eyes. Arch Ophthalmol. 1963;69:783-801.
8. Johnson M. What controls aqueous humour outflow resistance? Exp Eye Res. 2006;82:545-557. (Pubitemid 43122085)
9. Fautsch MP, Johnson DH. Aqueous humor outflow: what do we know? Where will it lead us? Invest Ophthalmol Vis Sci. 2006;47:4181-4187.
10. Ethier CR. The inner wall of Schlemm's canal. Exp Eye Res. 2002;74:161-172.
11. Acott TS, Kelley MJ. Extracellular matrix in the trabecular meshwork (review). Exp Eye Res. 2008;86:543-561.
12. Kaufman PL, Erickson KA. Cytochalasin B and D dose-outflow facility response relationships in the cynomolgus monkey. Invest Ophthalmol Vis Sci. 1982;23:646-650.
13. Sabanay I, Gabelt B, Tian B, Kaufman P, Geiger B. H-7 effects on the structure and fluid conductance of monkey trabecular meshwork. Arch Ophthalmol. 2000;118:955-962. (Pubitemid 30460635)
14. Bradley JMB, Vranka JA, Colvis CM, et al. Effects of matrix metalloproteinase activity on outflow in perfused human organ culture. Invest Ophthalmol Vis Sci. 1998;39:2649-2658.
15. Bárány EH, Scotchbrook S. Influence of testicular hyaluronidase on the resistance to flow through the angle of the anterior chamber. Acta Physiol Scand. 1954;30:240-248.
16. Johnson D. The effect of cytochalasin D on outflow facility and the trabecular meshwork of the human eye in perfusion organ culture. Invest Ophthalmol Vis Sci. 1997;38:2790-2799. (Pubitemid 28009401)
17. Knepper PA, Farbman AI, Telser AG. Exogenous hyaluronidases and degradation of hyaluronic acid in the rabbit eye. Invest Ophthalmol Vis Sci. 1984;25:286-293.
18. Epstein D, Rowlette L-L, Roberts B. Acto-myosin drug effects and aqueous outflow function. Invest Ophthalmol Vis Sci. 1999;40:74-81. (Pubitemid 29029574)
19. Rao PV, Deng P, Maddala R, Epstein DL, Li CY, Shimokawa H. Expression of dominant negative Rho-binding domain of Rhokinase in organ cultured human eye anterior segments increases aqueous humor outflow. Mol Vis. 2005;11:288-297. (Pubitemid 41358280)
20. Tian B, Kaufman PL, Volberg T, Gabelt BT, Geiger B. H-7 disrupts the actin cytoskeleton and increases outflow facility. Arch Ophthalmol. 1998;116:633-643. (Pubitemid 28414579)
21. Bradley JMB, Kelley MJ, Zhu XH, Anderssohn AM, Alexander JP, Acott TS. Effects of mechanical stretching on trabecular matrix metalloproteinases. Invest Ophthalmol Vis Sci. 2001;42:1505-1513.
22. Bradley JM, Kelley MJ, Rose A, Acott TS. Signaling pathways used in trabecular matrix metalloproteinase response to mechanical stretch. Invest Ophthalmol Vis Sci. 2003;44:5174-5181. (Pubitemid 37475386)
23. Vittitow J, Borras T. Genes expressed in the human trabecular meshwork during pressure-induced homeostatic response. J Cell Physiol. 2004;201:126-137. (Pubitemid 39187051)
24. Tumminia SJ, Mitton KP, Arora J, Zelenka P, Epstein PL, Russell P. Mechanical stretch alters the actin cytoskeletal network and signal transduction in human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 1998;39:1361-1371. (Pubitemid 28307361)
25. Vittal V, Rose A, Gregory KE, Kelley MJ, Acott TS. Changes in gene expression by trabecular meshwork cells in response to mechanical stretching. Invest Ophthalmol Vis Sci. 2005;46:2857-2868. (Pubitemid 43086708)
26. Keller KE, Kelley MJ, Acott TS. Extracellular matrix gene alternative splicing by trabecular meshwork cells in response to mechanical stretching. Invest Ophthalmol Vis Sci. 2007;48:1164-1172.
27. WuDunn D. The effect of mechanical strain on matrix metalloproteinase production by bovine trabecular meshwork cells. Curr Eye Res. 2001;22:394-397. (Pubitemid 34248300)
28. Okada Y, Matsuo T, Ohtsuki H. Bovine trabecular cells produce TIMP-1 and MMP-2 in response to mechanical stretching. Jpn J Ophthalmol. 1998;42:90-94. (Pubitemid 28254695)
29. Sato Y, Matouo T, Ohtsuki H. A novel gene (oculomedin) induced by mechanical stretching of human trabecular cells of the eye. Biochem Biophys Res Commun. 1999;259:349-351. (Pubitemid 29281235)
30. Stamer WD, Roberts BC, Epstein DL. Hydraulic pressure stimulates adenosine 3′,5′-cyclic monophosphate accumulation in endothelial cells from Schlemm's canal. Invest Ophthalmol Vis Sci. 1999;40:1983-1988.
31. Mitton KP, Tumminia SJ, Arora J, Zelenka P, Epstein DL, Russell P. Transient loss of αB-crystallin: an early cellular response to mechanical stretch. Biochem Biophys Res Commun. 1997;235:69-73. (Pubitemid 27302686)
32. Tamm ER, Russell P, Epstein DL, Johnson DH, Piatigorsky J. Modulation of myocillin: TIGR expression in human trabecular meshwork. Invest Ophthalmol Vis Sci. 1999;40:2577-2582. (Pubitemid 29455486)
33. Basbaum CB, Werb Z. Focalized proteolysis: spatial and temporal regulation of extracellular matrix degradation at the cell surface. Curr Opin Cell Biol. 1996;8:731-738. (Pubitemid 26381732)
34. Buccione R, Orth JD, McNiven MA. Foot and mouth: podosomes, invadopodia and circular dorsal ruffles. Nat Rev Mol Cell Biol. 2004;5:647-657. (Pubitemid 39025065)
35. Ayala I, Baldassarre M, Caldieri G, Buccione R. Invadopodia: a guided tour. Eur J Cell Biol. 2006;85:159-164.
36. Gimona M, Buccione R, Courtneidge SA, Linder S. Assembly and biological role of podosomes and invadopodia. Curr Opin Cell Biol. 2008;20:235-241.
37. Linder S. The matrix corroded: podosomes and invadopodia in extracellular matrix degradation. Trends Cell Biol. 2007;17:107-117. (Pubitemid 46341826)
38. Linder S, Aepfelbacher M. Podosomes: adhesion hot-spots of invasive cells. Trends Cell Biol. 2003;13:376-385. (Pubitemid 36776715)
39. Jurdic P, Saltel F, Chabadel A, Destaing O. Podosome and sealing zone: specificity of the osteoclast model. Eur J Cell Biol. 2006;85:195-202.
40. Spinardi L, Marchisio PC. Podosomes as smart regulators of cellular adhesion. Eur J Cell Biol. 2006;85:191-194.
41. Linder S, Kopp P. Podosomes at a glance. J Cell Sci. 2005;118:2079-2082.
42. Webb BA, Eves R, Mak AS. Cortactin regulates podosome formation: roles of the protein interaction domains. Exp Cell Res. 2006;312:760-769.
43. Artym VV, Zhang Y, Seillier-Moiseiwitsch F, Yamada KM, Mueller SC. Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function. Cancer Res. 2006;66:3034-3043.
44. Murphy G, Willenbrock F, Crabbe T, et al. Regulation of matrix metalloproteinase activity (review). Ann N Y Acad Sci. 1994;732:31-41.
45. Murphy G, Willenbrock F, Ward RV, Cockett MI, Eaton D, Docherty AJ. The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases. Biochem J. 1992;283:637-641.
46. Nagase H, Woessner J. Matrix metalloproteinases. J Biol Chem. 1999;274:21491-21494.
47. Parks W, Mecham R, eds. Matrix Metalloproteinases. San Diego, CA: Academic Press; 1998.
48. Fu X, Parks WC, Heinecke JW. Activation and silencing of matrix metalloproteinases. Semin Cell Dev Biol. 2008;19:2-13.
49. Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T. Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem. 2003;253:269-285.
50. Ochoa GC, Slepnev VI, Neff L, et al. A functional link between dynamin and the actin cytoskeleton at podosomes. J Cell Biol. 2000;150:377-389. (Pubitemid 30491360)
51. Huang J, Asawa T, Takato T, Sakai R. Cooperative roles of Fyn and cortactin in cell migration of metastatic murine melanoma. J Biol Chem. 2003;278:48367-48376. (Pubitemid 37523292)
52. Gu Z, Kordowska J, Williams GL, Wang CL, Hai CM. Erk1/2 MAPK and caldesmon differentially regulate podosome dynamics in A7r5 vascular smooth muscle cells. Exp Cell Res. 2007;313:849-866. (Pubitemid 46298559)
53. McNiven MA, Kim L, Krueger EW, Orth JD, Cao H, Wong TW. Regulated interactions between dynamin and the actin-binding protein cortactin modulate cell shape. J Cell Biol. 2000;151:187-198. (Pubitemid 30761131)
54. Alexander JP, Acott TS. Involvement of protein kinase C in TNFα regulation of trabecular matrix metalloproteinases and TIMPs. Invest Ophthalmol Vis Sci. 2001;42:2831-2838.
55. Alexander JP, Acott TS. Involvement of Erk-MAP kinase pathway in TNFα regulation of trabecular metalloproteinases and TIMPs. Invest Ophthalmol Vis Sci. 2003;44:164-169.
56. Alexander JP, Samples JR, Van Buskirk EM, Acott TS. Expression of matrix metalloproteinases and inhibitor by human trabecular meshwork. Invest Ophthalmol Vis Sci. 1991;32:172-180.
57. Polansky JR, Weinreb R, Alvarado JA. Studies on human trabecular cells propagated in vitro. Vision Res. 1981;21:155-160.
58. Polansky JR, Weinreb RN, Baxter JD, Alvarado J. Human trabecular cells. I. Establishment in tissue culture and growth characteristics. Invest Ophthalmol Vis Sci. 1979;18:1043-1049. (Pubitemid 9253760)
59. Stamer WD, Seftor RE, Williams SK, Samaha HA, Snyder RW. Isolation and culture of human trabecular meshwork cells by extracellular matrix digestion. Curr Eye Res. 1995;14:611-617.
60. Bradley JMB, Anderssohn AM, Colvis CM, et al. Mediation of laser trabeculoplasty-induced matrix metalloproteinase expression by IL-1β and TNFα. Invest Ophthalmol Vis Sci. 2000;41:422-430.
61. Johnson DH, Tschumper RC. The effect of organ culture on human trabecular meshwork. Exp Eye Res. 1989;49:113-127. (Pubitemid 19190157)
62. Johnson DH, Tschumper RC. Human trabecular meshwork organ culture. Invest Ophthalmol Vis Sci. 1987;28:945-953.
63. Bachmann B, Birke M, Kook D, Eichhorn M, Lütjen-Drecoll E. Ultrastructural and biochemical evaluation of the porcine anterior chamber perfusion model. Invest Ophthalmol Vis Sci. 2006;47:2011-2020. (Pubitemid 46768283)
64. Acott TS, Westcott M, Passo MS, Van Buskirk EM. Trabecular meshwork glycosaminoglycans in human and cynomolgus monkey eye. Invest Ophthalmol Vis Sci. 1985;26:1320-1329. (Pubitemid 15241054)
65. Keller KE, Bradley JM, Kelley MJ, Acott TS. Effects of modifiers of glycosaminoglycan biosynthesis on outflow facility in perfusion culture. Invest Ophthalmol Vis Sci. 2008;49:2495-2505.
66. Schmidt R, Wurm CA, Jakobs S, Engelhardt J, Egner A, Hell SW. Spherical nanosized focal spot unravels the interior of cells. Nat Methods. 2008;5:539-544. (Pubitemid 351761762)
67. Daly RJ. Cortactin signalling and dynamic actin networks. Biochem J. 2004;382:13-25. (Pubitemid 39141561)
68. Varon C, Tatin F, Moreau V, et al. Transforming growth factor beta induces rosettes of podosomes in primary aortic endothelial cells. Mol Cell Biol. 2006;26:3582-3594.
69. Machesky L, Jurdic P, Hinz B. Grab, stick, pull and digest: the functional diversity of actin-associated matrix-adhesion structures: workshop on invadopodia, podosomes and focal adhesions in tissue invasion. EMBO Rep. 2008;9:139-143. (Pubitemid 351223450)
70. Mao Y, Schwarzbauer JE. Stimulatory effects of a three-dimensional microenvironment on cell-mediated fibronectin fibrillogenesis. J Cell Sci. 2005;118:4427-4436. (Pubitemid 41556341)
71. Mao Y, Schwarzbauer JE. Fibronectin fibrillogenesis, a cell-mediated matrix assembly process. Matrix Biol. 2005;24:389-399. (Pubitemid 41765018)
72. Johnson DH, Richardson TM, Epstein DL. Trabecular meshwork recovery after phagocytic challenge. Curr Eye Res. 1989;8:1121-1130.
73. Acott TS, Samples JR, Bradley JMB, Bacon DR, Bylsma SS, Van Buskirk EM. Trabecular repopulation by anterior trabecular meshwork cells after laser trabeculoplasty. Am J Ophthalmol. 1989;107:1-6. (Pubitemid 19028359)
74. Clark AF, Wilson K, McCartney MD, Miggans ST, Kunkle M, Howe W. Glucocorticoid-induced formation of cross-linked actin networks in cultured human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 1994;35:281-294. (Pubitemid 24046852)
75. Clark AF, Brotchie D, Read AT, et al. Dexamethasone alters F-actin architecture and promotes cross-linked actin network formation in human trabecular meshwork tissue. Cell Motil Cytoskeleton. 2005;60:83-95. (Pubitemid 40165322)
76. Filla MS, Woods A, Kaufman PL, Peters DM. Beta1 and beta3 integrins cooperate to induce syndecan-4-containing cross-linked actin networks in human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2006;47:1956-1967. (Pubitemid 46768276)
77. Gabelt BT, Hu Y, Vittitow JL, et al. Caldesmon transgene expression disrupts focal adhesions in HTM cells and increases outflow facility in organ-cultured human and monkey anterior segments. Exp Eye Res. 2006;82:935-944.
78. Grosheva I, Vittitow JL, Goichberg P, et al. Caldesmon effects on the actin cytoskeleton and cell adhesion in cultured HTM cells. Exp Eye Res. 2006;82:945-958. (Pubitemid 44287907)
79. Hai CM, Gu Z. Caldesmon phosphorylation in actin cytoskeletal remodeling. Eur J Cell Biol. 2006;85:305-309.
80. Wang CL. Caldesmon and smooth-muscle regulation. Cell Biochem Biophys. 2001;35:275-288.
81. Dabrowska R, Kulikova N, Gagola M. Nonmuscle caldesmon: its distribution and involvement in various cellular processes (review). Protoplasma. 2004;224:1-13. (Pubitemid 39403881)
82. Eves R, Webb BA, Zhou S, Mak AS. Caldesmon is an integral component of podosomes in smooth muscle cells. J Cell Sci. 2006;119:1691-1702. (Pubitemid 43810996)
83. Mizutani K, Miki H, He H, Maruta H, Takenawa T. Essential role of neural Wiskott-Aldrich syndrome protein in podosome formation and degradation of extracellular matrix in src-transformed fibroblasts. Cancer Res. 2002;62:669-674. (Pubitemid 34126939)
84. Yamaguchi H, Lorenz M, Kempiak S, et al. Molecular mechanisms of invadopodium formation: the role of the N-WASP-Arp2/3 complex pathway and cofilin. J Cell Biol. 2005;168:441-452. (Pubitemid 40205066)
85. Takenawa T, Suetsugu S. The WASP-WAVE protein network: connecting the membrane to the cytoskeleton. Nat Rev Mol Cell Biol. 2007;8:37-48. (Pubitemid 46012013)
86. Rohatgi R, Ma L, Miki H, et al. The interaction between N-WASP and the Arp2/3 complex links Cdc42-dependent signals to actin assembly. Cell. 1999;97:221-231. (Pubitemid 129746811)
87. Weaver AM, Heuser JE, Karginov AV, Lee WL, Parsons JT, Cooper JA. Interaction of cortactin and N-WASp with Arp2/3 complex. Curr Biol. 2002;12:1270-1278.
88. Caron E. Regulation of Wiskott-Aldrich syndrome protein and related molecules. Curr Opin Cell Biol. 2002;14:82-87. (Pubitemid 34131661)
89. Stradal TE, Rottner K, Disanza A, Confalonieri S, Innocenti M, Scita G. Regulation of actin dynamics by WASP and WAVE family proteins. Trends Cell Biol. 2004;14:303-311. (Pubitemid 38798179)
90. Guerriero CJ, Weisz OA. N-WASP inhibitor wiskostatin nonselectively perturbs membrane transport by decreasing cellular ATP levels. Am J Physiol Cell Physiol. 2007;292:C1562-C1566.
91. Leung DW, Morgan DM, Rosen MK. Biochemical properties and inhibitors of (N-)WASP. Methods Enzymol. 2006;406:281-296.
92. Inomata H, Bill A, Smelser GK. Aqueous humor pathways through the trabecular meshwork and into Schlemm's canal in the cynomolgus monkey (Macaca irus): an electron microscopic study. Am J Ophthalmol. 1972;73:760.
93. Grierson I, Lee WR, Abraham S, Howes RC. Associations between the cells of the walls of Schlemm's canal. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1978;208:33-47. (Pubitemid 9008378)
94. Carr DW, Acott TS. Intracellular pH regulates bovine sperm motility and protein phosphorylation. Biol Reprod. 1989;41:907-920.